# Intravenous Iron in Patients With Systolic Heart Failure and Iron Deficiency to Improve Morbidity & Mortality

Study · id `cardio:ct-nct03036462` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03036462](<https://clinicaltrials.gov/study/NCT03036462>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03036462

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1105 participants.

## Technical summary

Registry record NCT03036462. Randomized; triple masking; primary purpose treatment. Start 2017-03-07 (actual); primary completion 2024-05-02 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; triple masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 1105 participants (enrolled count; ClinicalTrials.gov record NCT03036462, source copy `cardio:ctgov-nct03036462-2025-01-28`, retrieved 2026-10-26)
- Started: 2017-03-07 (actual) (ClinicalTrials.gov record NCT03036462, source copy `cardio:ctgov-nct03036462-2025-01-28`, retrieved 2026-10-26)
- Primary completion: 2024-05-02 (actual) (ClinicalTrials.gov record NCT03036462, source copy `cardio:ctgov-nct03036462-2025-01-28`, retrieved 2026-10-26)
- Completion: 2024-05-02 (actual) (ClinicalTrials.gov record NCT03036462, source copy `cardio:ctgov-nct03036462-2025-01-28`, retrieved 2026-10-26)
- Countries: Germany; Hungary; Italy; Poland; Portugal; Slovenia; Spain (ClinicalTrials.gov record NCT03036462, source copy `cardio:ctgov-nct03036462-2025-01-28`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03036462-2025-01-28`, retrieved 2026-10-26)

## The registry's words

- Brief title: Intravenous Iron in Patients With Systolic Heart Failure and Iron Deficiency to Improve Morbidity & Mortality
- Acronym: FAIR-HF2
- Condition: Systolic Heart Failure
- Condition: Iron Deficiency
- Intervention (Drug): Iron
- Intervention (Drug): Saline
- Lead sponsor: Universitätsklinikum Hamburg-Eppendorf
- Lead sponsor class: OTHER
- Collaborator: Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK)
- Collaborator class: OTHER
- Collaborator: Charite University, Berlin, Germany
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry condition terms include this condition: Heart failure with reduced ejection fraction (HFrEF) (`cardio:hfref`)
- Registry lists this organization as the lead sponsor: Universitätsklinikum Hamburg-Eppendorf (`cardio:org-universitatsklinikum-hamburg-eppendorf`)
- Registry lists this organization as a collaborator: Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK) (`cardio:org-deutsches-zentrum-fur-herz-kreislauf-forschung-dzhk`)
- Registry lists this organization as a collaborator: Charite University, Berlin, Germany (`cardio:org-charite-university-berlin-germany`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Intravenous Ferric Carboxymaltose in Heart Failure With Iron Deficiency: The FAIR-HF2 DZHK05 Randomized Clinical Trial (`cardio:pubmed-40159390`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Intravenous ferric carboxymaltose in heart failure with iron deficiency (FAIR-HF2 DZHK05 trial): Sex-specific outcomes (`cardio:pubmed-40740027`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 487218b4c0013bb635583974130540008bb633cf5491e2b0f62987fad8b93b16
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
